Gyre Therapeutics, Inc. (GYRE) — SC 13D/A Filings
All SC 13D/A filings from Gyre Therapeutics, Inc.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
GNI Group Amends Gyre Therapeutics Stake; Signals Ownership Change
— Jan 24, 2024
GNI Group Ltd. filed an amended Schedule 13D/A on January 24, 2024, updating its beneficial ownership in Gyre Therapeutics, Inc. This amendment, filed due to an
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX